Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VKTX Relative to the S&P 500

VKTX Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Viking Therapeutics, Inc. (NASD:VKTX) seasonal charts above shows that a Buy Date of August 3 and a Sell Date of November 5 has resulted in a geometric average return of 11.22% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 1.03% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

To download VKTX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VKTX